Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 34.80B | 35.14B | 34.78B | 36.50B | 34.77B | 30.87B |
Gross Profit | 7.51B | 7.53B | 7.23B | 7.81B | 6.48B | 6.34B |
EBITDA | 2.69B | 2.76B | 2.79B | 3.08B | 1.90B | 1.92B |
Net Income | 1.52B | 1.43B | 1.51B | 1.76B | 863.13M | 1.00B |
Balance Sheet | ||||||
Total Assets | 26.79B | 25.87B | 24.96B | 23.97B | 22.48B | 21.54B |
Cash, Cash Equivalents and Short-Term Investments | 6.42B | 8.87B | 7.58B | 6.59B | 5.00B | 5.05B |
Total Debt | 1.42B | 1.32B | 1.60B | 1.71B | 1.83B | 1.99B |
Total Liabilities | 7.95B | 7.05B | 7.23B | 7.40B | 7.26B | 6.87B |
Stockholders Equity | 17.18B | 17.11B | 16.15B | 15.10B | 13.86B | 13.38B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.14B | 1.60B | 2.09B | 396.09M | 704.29M |
Operating Cash Flow | 0.00 | 2.43B | 1.84B | 2.20B | 550.67M | 2.16B |
Investing Cash Flow | 0.00 | -509.56M | -119.69M | -97.46M | -42.75M | -1.22B |
Financing Cash Flow | 0.00 | -833.93M | -729.54M | -512.25M | -565.81M | -625.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥9.80B | 6.85 | 5.56% | 1.02% | -5.01% | ||
73 Outperform | ¥8.48B | 6.81 | 3.56% | 8.63% | 9.65% | ||
73 Outperform | ¥9.67B | 4.86 | 5.55% | 1.49% | 78.77% | ||
72 Outperform | ¥10.05B | 5.56 | 3.69% | -4.87% | -19.11% | ||
63 Neutral | ¥14.75B | 234.03 | 4.43% | 2.22% | -90.98% | ||
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% | |
51 Neutral | ¥8.79B | ― | 3.25% | 24.16% | 93.49% |